STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linlin, Xiao, Ping, Meng, Fanlu, Zhong, Diansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601241/
https://www.ncbi.nlm.nih.gov/pubmed/36290807
http://dx.doi.org/10.3390/curroncol29100530
_version_ 1784817010477105152
author Zhang, Linlin
Xiao, Ping
Meng, Fanlu
Zhong, Diansheng
author_facet Zhang, Linlin
Xiao, Ping
Meng, Fanlu
Zhong, Diansheng
author_sort Zhang, Linlin
collection PubMed
description STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic strategy selecting of NSCLC patients harboring STRN-ALK fusion.
format Online
Article
Text
id pubmed-9601241
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96012412022-10-27 STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report Zhang, Linlin Xiao, Ping Meng, Fanlu Zhong, Diansheng Curr Oncol Case Report STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic strategy selecting of NSCLC patients harboring STRN-ALK fusion. MDPI 2022-09-21 /pmc/articles/PMC9601241/ /pubmed/36290807 http://dx.doi.org/10.3390/curroncol29100530 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Zhang, Linlin
Xiao, Ping
Meng, Fanlu
Zhong, Diansheng
STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_full STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_fullStr STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_full_unstemmed STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_short STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_sort strn-alk fusion in lung adenocarcinoma with brain metastasis responded well to ensartinib: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601241/
https://www.ncbi.nlm.nih.gov/pubmed/36290807
http://dx.doi.org/10.3390/curroncol29100530
work_keys_str_mv AT zhanglinlin strnalkfusioninlungadenocarcinomawithbrainmetastasisrespondedwelltoensartinibacasereport
AT xiaoping strnalkfusioninlungadenocarcinomawithbrainmetastasisrespondedwelltoensartinibacasereport
AT mengfanlu strnalkfusioninlungadenocarcinomawithbrainmetastasisrespondedwelltoensartinibacasereport
AT zhongdiansheng strnalkfusioninlungadenocarcinomawithbrainmetastasisrespondedwelltoensartinibacasereport

Ejemplares similares